Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice

Published:2022-01 Issue:1 Volume:148 Page:134-141
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Sugahara Shingo,Hanaoka Kaori,Emori Takashi,Takeshita Nobuaki,Fujii Yasutomo,Nakano Masaki,Suzuki Takako,Takahashi Jun,Nakamura Yukio

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis;Orsolini;Pharmacol Res,2019

2. Pharmacological management of osteoporosis in rheumatoid arthritis patients: a Review of the literature and practical guide;Raterman;Drugs Aging,2019

3. Clinical immunity in bone and joints;Tanaka;J Bone Miner Metabol,2019

4. Evidence for osteocyte regulation of bone homeostasis through RANKL expression;Nakashima;Nat Med,2011

5. Matrix-embedded cells control osteoclast formation;Xiong;Nat Med,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy;International Journal of Molecular Sciences;2024-07-30

2. Suppression of TNF‐α activity by immobilization rescues Mkx expression and attenuates tendon ossification in a mouse Achilles tenotomy model;Journal of Orthopaedic Research;2024-05-28

3. The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches;Clinical Rheumatology;2024-03-18

4. Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss;Inflammation and Regeneration;2023-09-19

5. Comparison of the effects of peficitinib and tofacitinib in the adjuvant-induced arthritis rat model;European Journal of Pharmacology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3